GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $7,972,000 | +9.3% | 169,621 | -0.8% | 0.06% | +1.9% |
Q3 2019 | $7,297,000 | +4.4% | 170,941 | -2.1% | 0.05% | 0.0% |
Q2 2019 | $6,990,000 | -1.1% | 174,625 | +3.2% | 0.05% | -6.9% |
Q1 2019 | $7,071,000 | +21.6% | 169,185 | +11.2% | 0.06% | +1.8% |
Q4 2018 | $5,817,000 | +5.0% | 152,198 | +10.4% | 0.06% | +1.8% |
Q3 2018 | $5,541,000 | +17.4% | 137,904 | +17.8% | 0.06% | -13.8% |
Q2 2018 | $4,718,000 | +1.2% | 117,051 | -1.9% | 0.06% | +1.6% |
Q1 2018 | $4,663,000 | +9.0% | 119,295 | -1.1% | 0.06% | +12.3% |
Q4 2017 | $4,277,000 | +4.1% | 120,590 | +19.2% | 0.06% | -12.3% |
Q3 2017 | $4,109,000 | +9.3% | 101,199 | +16.1% | 0.06% | -1.5% |
Q2 2017 | $3,759,000 | +16.5% | 87,194 | +14.0% | 0.07% | +1.5% |
Q1 2017 | $3,226,000 | +18.7% | 76,503 | +8.4% | 0.06% | +6.6% |
Q4 2016 | $2,718,000 | -9.1% | 70,556 | +1.8% | 0.06% | -15.3% |
Q3 2016 | $2,991,000 | +4.5% | 69,331 | +4.8% | 0.07% | -4.0% |
Q2 2016 | $2,863,000 | – | 66,125 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |